
pmid: 16434201
A series of novel chalcones and bis-chalcones containing boronic acid moieties has been synthesized and evaluated for antitumor activity against the human breast cancer MDA-MB-231 (estrogen receptor-negative) and MCF7 (estrogen receptor-positive) cell lines and against two normal breast epithelial cell lines, MCF-10A and MCF-12A. These molecules inhibited the growth of the human breast cancer cell lines at low micromolar to nanomolar concentrations, with five of them (1-4, 9) showing preferential inhibition of the human breast cancer cell lines. Furthermore, bis-chalcone 8 exhibited a more potent inhibition of colon cancer cells expressing wild-type p53 than of an isogenic cell line that was p53-null.
Dose-Response Relationship, Drug, Molecular Structure, Antineoplastic Agents, Breast Neoplasms, Boronic Acids, Lethal Dose 50, Chalones, Piperidines, Cell Line, Tumor, Colonic Neoplasms, Humans, Female, Drug Screening Assays, Antitumor
Dose-Response Relationship, Drug, Molecular Structure, Antineoplastic Agents, Breast Neoplasms, Boronic Acids, Lethal Dose 50, Chalones, Piperidines, Cell Line, Tumor, Colonic Neoplasms, Humans, Female, Drug Screening Assays, Antitumor
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 377 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
